JACOBS LEVY EQUITY MANAGEMENT, INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$253,950
-86.8%
37,903
-87.2%
0.00%
-91.7%
Q1 2023$1,922,214
-24.5%
295,271
-1.1%
0.01%
-29.4%
Q4 2022$2,547,195
+7.0%
298,616
-33.8%
0.02%
-10.5%
Q3 2022$2,380,000450,8340.02%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 3,009,677$25,672,5449.37%
Nextech Invest Ltd. 1,910,029$16,292,5476.48%
K2 PRINCIPAL FUND, L.P. 2,872,148$24,499,4223.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$94,494,7171.96%
Orbimed Advisors 8,740,887$74,559,7661.43%
SECTORAL ASSET MANAGEMENT INC 782,410$6,673,9571.29%
Rubric Capital Management LP 2,990,564$25,509,5111.11%
Oasis Management Co Ltd. 317,662$2,709,6570.54%
RA Capital Management 3,009,678$25,672,5530.52%
TANG CAPITAL MANAGEMENT LLC 409,463$3,492,7190.51%
View complete list of SILVERBACK THERAPEUTICS INC shareholders